Capital Fund Management »

Intellia Therapeutics shares owned by Capital Fund Management

Quarter-by-quarter ownership of Intellia Therapeutics (NTLA) shares owned by Capital Fund Management from 13F filings

Historical chart of Capital Fund Management investment in Intellia Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Intellia Therapeutics held by Capital Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intellia Therapeutics by Capital Fund Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $7.5M 274k 27.51
2023-09-30 $2.1M 65k 31.62
2023-03-31 $4.0M 108k 37.27
2022-12-31 $3.8M 110k 34.89
2021-03-31 $939k 12k 80.26

More positions owned by Capital Fund Management

NVIDIA Corporation Call Option (NVDA)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Meta Platforms Cl A Call Option (META)
JPMorgan Chase & Co. Call Option (JPM)
Microsoft Corporation Call Option (MSFT)
Bank of America Corporation (BAC)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Eli Lilly & Co. Call Option (LLY)
Spdr Dow Jones Indl Average Ut Ser 1 Call Option (DIA)
Paypal Holdings (PYPL)
Tesla Motors Call Option (TSLA)
Super Micro Computer Call Option (SMCI)
Citigroup Com New (C)

View all positions for Capital Fund Management

Top funds holding Intellia Therapeutics

ARK Investment Management
BlackRock
Vanguard Group
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
Morgan Stanley
Wellington Management Company
FMR
Geode Capital Management
Federated Investors
Casdin Capital
Alliancebernstein
T. Rowe Price Associates
Rokos Capital Management
Contrarius Investment Management

View all funds holding Intellia Therapeutics